There has been no measurement of the cost to the public purse of requiring medical professionals to disclose payments and gifts from medical and other suppliers.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"} } , "answeringMemberConstituency" : {"_value" : "Wimbledon"} , "answeringMemberPrinted" : {"_value" : "Stephen Hammond"} , "dateOfAnswer" : {"_value" : "2019-04-01", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-04-01T15:23:07.003Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-03-25", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Health Professions: Business Interests"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what the cost to the public purse has been of requiring medical professionals to disclose payments and gifts from medical and other suppliers; and what benefits have been derived from the implementing that requirement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4604", "label" : {"_value" : "Biography information for Stephen Kerr"} } , "tablingMemberConstituency" : {"_value" : "Stirling"} , "tablingMemberPrinted" : [{"_value" : "Stephen Kerr"} ], "uin" : "236538"} , {"_about" : "http://data.parliament.uk/resources/1064905", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1064905/answer", "answerText" : {"_value" : "
\u2018The Collaborative Tuberculosis (TB) Strategy for England 2015 to 2020\u2019 was developed by Public Health England (PHE) in partnership with NHS England and aims to reduce suffering and harm caused by TB through lowering the incidence of the disease in England. The Strategy is available at the following link:<\/p>
<\/p>
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/403231/Collaborative_TB_Strategy_for_England_2015_2020_.pdf<\/a><\/p> <\/p> The strategy aims to tackle TB in under-served populations through the commissioning of integrated, multidisciplinary, case management and support for under-served groups. This multidisciplinary support, which may include third sector organisations, should provide targeted outreach interventions, informed by proven models such as \u2018Find and Treat\u2019 in London, including specific services for active case finding among homeless people and those attending substance misuse services.<\/p> <\/p> In January 2016, the National Institute for Health and Care Excellence published a clinical guideline that covers preventing, identifying and managing latent and active TB in children, young people and adults. This is available at the following link:<\/p> <\/p>